4-chloro-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 1310373-51-3

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: 4-chloro-pyridine-2-carboxylic acid [3-((S)-2-amino-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide
• 英文别名: N-[3-[(4S)-2-amino-4-methyl-5,6-dihydro-1,3-oxazin-4-yl]-4-fluorophenyl]-4-chloropyridine-2-carboxamide
• CAS: 1310373-51-3
• 化学式: C₁₇H₁₆ClFN₄O₂
• 分子量: 362.791
• InChiKey: ARQUKIZYMZJWRZ-KRWDZBQOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  89.6
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] AMINO OXAZINE DERIVATIVES<br/>[FR] DÉRIVÉS D'AMINO-OXAZINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011070029A1

  公开（公告）日：2011-06-16

  This invention relates to 5,6-dihydro-4H-[1,3]oxazin-2-ylamine compounds of the formula (I) wherein R1 to R5 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.

  这项发明涉及式(I)的5,6-二氢-4H-[1,3]噁嗪-2-胺类化合物，其中R1至R5如描述和权利要求中定义的那样，以及其药用盐。这些化合物是BACE2抑制剂，可用作治疗或预防糖尿病等疾病的药物。
• AMINO OXAZINE DERIVATIVES
  申请人：Banner David

  公开号：US20110144098A1

  公开（公告）日：2011-06-16

  This invention relates to 5,6-dihydro-4H-[1,3]oxazin-2-ylamine compounds of the formula wherein R 1 to R 5 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.

  这项发明涉及式中R1至R5如描述和索赔中所定义的5,6-二氢-4H-[1,3]噁唑啉-2-胺化合物，以及其药学上可接受的盐。这些化合物是BACE2抑制剂，可用作治疗或预防糖尿病等疾病的药物。
• US7964594B1
  申请人：——

  公开号：US7964594B1

  公开（公告）日：2011-06-21